
Daré Bioscience DARE
€ 0.69
4.73%
Daré Bioscience EV/EBITDA | DARE
EV/EBITDA Jährlich Daré Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.83 | -1.58 | -0.628 | -2.66 | -2.25 | -0.00245 | -0.895 | -0.15 | 0.165 | 0.00645 | -0.147 | -3.22 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.165 | -3.22 | -1.1 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AnaptysBio
ANAB
|
45.1 | $ 51.0 | 1.83 % | $ 1.48 B | ||
|
Allakos
ALLK
|
-0.000271 | - | - | $ 28.6 M | ||
|
Black Diamond Therapeutics
BDTX
|
10.5 | $ 1.88 | 0.53 % | $ 107 M | ||
|
Clovis Oncology
CLVS
|
-19.7 | - | -7.23 % | $ 13 M | ||
|
Concert Pharmaceuticals
CNCE
|
-0.207 | - | - | $ 401 M | ||
|
Evelo Biosciences
EVLO
|
-0.456 | - | -14.46 % | $ 27.9 M | ||
|
BioMarin Pharmaceutical
BMRN
|
24.3 | $ 60.26 | 0.06 % | $ 11.6 B | ||
|
BioNTech SE
BNTX
|
-12.2 | $ 98.52 | 0.24 % | $ 23.8 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 2.17 | 0.46 % | $ 3.57 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-2.56 | - | - | $ 384 M | ||
|
Genocea Biosciences
GNCA
|
-1.28 | - | -15.0 % | $ 3.04 M | ||
|
Catalyst Biosciences
CBIO
|
70.6 | $ 13.99 | 0.84 % | $ 1.25 B | ||
|
C4 Therapeutics
CCCC
|
-2.31 | $ 2.98 | 0.3 % | $ 247 M | ||
|
Codexis
CDXS
|
-4.31 | $ 1.32 | 1.09 % | $ 115 M | ||
|
Amryt Pharma plc
AMYT
|
-75 | - | - | $ 621 M | ||
|
Cerus Corporation
CERS
|
-87.2 | $ 2.62 | 0.38 % | $ 499 M | ||
|
G1 Therapeutics
GTHX
|
-5.82 | - | - | $ 370 M | ||
|
Coherus BioSciences
CHRS
|
-1.86 | $ 1.13 | 0.43 % | $ 132 M | ||
|
Celldex Therapeutics
CLDX
|
-7.28 | $ 31.1 | 1.16 % | $ 2.07 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-0.355 | $ 4.25 | 3.16 % | $ 51.9 M | ||
|
Cellectar Biosciences
CLRB
|
0.0286 | $ 1.8 | 0.72 % | $ 4.69 M | ||
|
AbbVie
ABBV
|
24.9 | $ 264.34 | 0.09 % | $ 468 B | ||
|
Humanigen
HGEN
|
-0.883 | - | -81.12 % | $ 4.28 M | ||
|
Cocrystal Pharma
COCP
|
-0.867 | $ 1.17 | 1.74 % | $ 13.2 M | ||
|
AbCellera Biologics
ABCL
|
-6.16 | $ 12.7 | 0.4 % | $ 3.79 B | ||
|
Abeona Therapeutics
ABEO
|
-2.69 | $ 5.4 | 2.65 % | $ 286 M | ||
|
Collegium Pharmaceutical
COLL
|
38.8 | $ 22.53 | 0.2 % | $ 713 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
83.2 | $ 116.1 | 4.93 % | $ 12.1 B | ||
|
Фармсинтез
LIFE
|
-115 | - | - | - | ||
|
IGM Biosciences
IGMS
|
-1.38 | - | - | $ 76.9 M | ||
|
IMV
IMV
|
-3.88 | - | - | $ 13.1 M | ||
|
Kinnate Biopharma
KNTE
|
-0.674 | - | - | $ 123 M | ||
|
Cardiff Oncology
CRDF
|
-2.37 | $ 1.24 | 0.74 % | $ 82.9 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.186 | - | - | $ 231 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-1.4 | $ 7.14 | 0.19 % | $ 95.1 M | ||
|
Karuna Therapeutics
KRTX
|
-23.7 | - | - | $ 12.2 B | ||
|
Curis
CRIS
|
-3.41 | $ 0.83 | 1.1 % | $ 10.9 M | ||
|
CorMedix
CRMD
|
1.83 | $ 7.85 | 1.03 % | $ 565 K | ||
|
Crinetics Pharmaceuticals
CRNX
|
-8.07 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
CRISPR Therapeutics AG
CRSP
|
-6.79 | $ 54.23 | 0.23 % | $ 4.88 B | ||
|
Champions Oncology
CSBR
|
392 | $ 4.9 | 0.1 % | $ 67.8 M | ||
|
Chimerix
CMRX
|
0.0697 | - | - | $ 756 M | ||
|
Corvus Pharmaceuticals
CRVS
|
-7.55 | $ 11.62 | 8.21 % | $ 918 M | ||
|
Cue Biopharma
CUE
|
-0.704 | $ 31.41 | 1.45 % | $ 2.98 B | ||
|
CEL-SCI Corporation
CVM
|
-0.928 | $ 1.67 | 2.38 % | $ 13.4 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-22.4 | $ 4.85 | 0.2 % | $ 929 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-3.27 | $ 64.66 | 0.17 % | $ 7.77 M | ||
|
Adagene
ADAG
|
-8.38 | $ 2.93 | 2.86 % | $ 173 M | ||
|
DiaMedica Therapeutics
DMAC
|
-8.63 | $ 7.94 | 1.4 % | $ 373 M |